Jimmie H. Harvey

A Double-Blind, Placebo-Controlled Trial of Ruxolitinib for Myelofibrosis

Srđan Verstovšek, Ruben A. Mesa, Jason Gotlib et al. · New England Journal of Medicine · 2012 · 2K citations · Full text

Efficacy, safety, and survival with ruxolitinib in patients with myelofibrosis: results of a median 3-year follow-up of COMFORT-I

Srđan Verstovšek, Ruben A. Mesa, Jason Gotlib et al. · Haematologica · 2015 · 325 citations · Full text

Effect of Ruxolitinib Therapy on Myelofibrosis-Related Symptoms and Other Patient-Reported Outcomes in COMFORT-I: A Randomized, Double-Blind, Placebo-Controlled Trial

Ruben A. Mesa, Jason Gotlib, Vikas Gupta et al. · Journal of Clinical Oncology · 2013 · 189 citations · Full text

Efficacy, safety and survival with ruxolitinib in patients with myelofibrosis: results of a median 2-year follow-up of COMFORT-I

Srđan Verstovšek, Ruben A. Mesa, Jason Gotlib et al. · Haematologica · 2013 · 161 citations · Full text

Hematological Malignancy, Oncology, Malignant Blood Disorder +12

Phase II Trial of Mapatumumab, a Fully Human Agonist Monoclonal Antibody to Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand Receptor 1 (TRAIL-R1), in Combination With Paclitaxel and Carboplatin in Patients With Advanced Non–Small-Cell Lung Cancer

Joachim von Pawel, Jimmie H. Harvey, David R. Spigel et al. · Clinical Lung Cancer · 2014 · 97 citations

Phase Ii Trial, Medicine, Immunology +7